2008
DOI: 10.2174/157018008783406723
|View full text |Cite
|
Sign up to set email alerts
|

Classical and Fragment-Based Hologram Structure-Activity Relationships for a Series of Analgesic Cyclic Imides

Abstract: Cyclic imides have been widely employed in drug design research due to their multiple pharmacological and biological properties. In the present study, two-dimensional quantitative structure-activity relationship (2D QSAR) studies were conducted on a series of potent analgesic cyclic imides using both classical and hologram QSAR (HQSAR) methods, yielding significant statistical models (classical QSAR, q 2 = 0.80; HQSAR, q 2 = 0.84). The models were then used to evaluate an external data test, and the predicted … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2009
2009
2021
2021

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 15 publications
0
1
0
Order By: Relevance
“…The imide core is also present in compounds whose activity is related to CNS activity [ 32 , 33 , 34 , 35 , 36 ]. In particular, much attention has been paid to their ability to inhibit cyclooxygenases, anti-inflammatory, and analgetic activity [ 37 , 38 , 39 , 40 , 41 , 42 , 43 , 44 , 45 , 46 , 47 ]. To date, several drugs with cyclic imide structure have been approved, including lurasidone, buspirone, ethosuximide, mesuximide, and the IMiDs class includes thalidomide and its analogues lenalidomide, pomalidomide, apremilast ( Figure 1 ).…”
Section: Introductionmentioning
confidence: 99%
“…The imide core is also present in compounds whose activity is related to CNS activity [ 32 , 33 , 34 , 35 , 36 ]. In particular, much attention has been paid to their ability to inhibit cyclooxygenases, anti-inflammatory, and analgetic activity [ 37 , 38 , 39 , 40 , 41 , 42 , 43 , 44 , 45 , 46 , 47 ]. To date, several drugs with cyclic imide structure have been approved, including lurasidone, buspirone, ethosuximide, mesuximide, and the IMiDs class includes thalidomide and its analogues lenalidomide, pomalidomide, apremilast ( Figure 1 ).…”
Section: Introductionmentioning
confidence: 99%